Yuanming Shen

1.8k total citations · 1 hit paper
35 papers, 1.0k citations indexed

About

Yuanming Shen is a scholar working on Cancer Research, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Yuanming Shen has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 11 papers in Molecular Biology and 11 papers in Reproductive Medicine. Recurrent topics in Yuanming Shen's work include Ovarian cancer diagnosis and treatment (10 papers), Cancer-related molecular mechanisms research (10 papers) and Cervical Cancer and HPV Research (7 papers). Yuanming Shen is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Cancer-related molecular mechanisms research (10 papers) and Cervical Cancer and HPV Research (7 papers). Yuanming Shen collaborates with scholars based in China, Switzerland and Germany. Yuanming Shen's co-authors include Weiguo Lü, Xing Xie, Xiaoyun Wan, Junfen Xu, Fenfen Wang, Feng Ye, Jiansong Zhou, Xiaodong Cheng, Sangsang Tang and Yang Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yuanming Shen

30 papers receiving 1.0k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer

2022 138 citations Junfen Xu, Yifeng Fang et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuanming Shen China	15	681	601	151	114	111	35	1.0k
Tetsushi Tsuruga Japan	14	749 1.1×	534 0.9×	194 1.3×	91 0.8×	138 1.2×	47	1.1k
Martina Ring Ireland	13	649 1.0×	474 0.8×	160 1.1×	201 1.8×	93 0.8×	19	974
John Wallbillich United States	10	386 0.6×	292 0.5×	143 0.9×	122 1.1×	100 0.9×	29	659
Bo‐Wei Han China	10	490 0.7×	499 0.8×	75 0.5×	44 0.4×	111 1.0×	23	746
Dilu Feng China	14	370 0.5×	219 0.4×	180 1.2×	38 0.3×	99 0.9×	26	649
Erika Nakatsuka Japan	9	535 0.8×	488 0.8×	109 0.7×	24 0.2×	118 1.1×	20	742
Huaizeng Chen China	16	514 0.8×	165 0.3×	280 1.9×	72 0.6×	144 1.3×	44	788
Nana Tchabo United States	14	326 0.5×	190 0.3×	235 1.6×	67 0.6×	107 1.0×	25	744
Alexander J. Cole Australia	14	357 0.5×	132 0.2×	164 1.1×	100 0.9×	184 1.7×	31	775

Countries citing papers authored by Yuanming Shen

Since Specialization

Citations

This map shows the geographic impact of Yuanming Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanming Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanming Shen more than expected).

Fields of papers citing papers by Yuanming Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanming Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanming Shen. The network helps show where Yuanming Shen may publish in the future.

Co-authorship network of co-authors of Yuanming Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanming Shen. A scholar is included among the top collaborators of Yuanming Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanming Shen. Yuanming Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Yuanming, Sangsang Tang, Yumei Zhou, et al.. (2024). Human Papillomavirus Genotype Attribution and Integration in High-Grade Vaginal Intraepithelial Neoplasia. Journal of Lower Genital Tract Disease. 29(1). 60–67.

Shen, Yuanming, Beihua Kong, Bairong Xia, et al.. (2023). Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial.. Journal of Clinical Oncology. 41(16_suppl). 5556–5556. 1 indexed citations

Zhou, Qi, Gang Chen, Yuanming Shen, et al.. (2023). Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103). Journal of Gynecologic Oncology. 34(3). e55–e55. 3 indexed citations

Xu, Junfen, et al.. (2023). Secondary cytoreduction surgery for recurrent epithelial ovarian cancer patients after PARPi maintenance: A multicenter, randomized, controlled clinical trial. International Journal of Gynecological Cancer. 34(2). 328–331. 4 indexed citations

Lv, Weiguo, et al.. (2022). Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ. Journal of Gynecologic Oncology. 34(1). e8–e8. 2 indexed citations

Xu, Junfen, Yifeng Fang, Kelie Chen, et al.. (2022). Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 28(16). 3590–3602. 138 indexed citations breakdown →

Tang, Sangsang, et al.. (2022). Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer. Cell Death and Disease. 13(9). 826–826. 46 indexed citations

Li, Jingnan, Yu Wang, Bingjian Lü, et al.. (2022). Gestational trophoblastic neoplasia with extrauterine metastasis but lacked uterine primary lesions: a single center experience and literature review. BMC Cancer. 22(1). 509–509. 6 indexed citations

Xu, Junfen, Yuanming Shen, Conghui Wang, et al.. (2021). Arsenic compound sensitizes homologous recombination proficient ovarian cancer to PARP inhibitors. Cell Death Discovery. 7(1). 259–259. 16 indexed citations

10.

Bai, Hao, Ruojun Wang, Yuanming Shen, et al.. (2020). Evaluation of Concordance Between Deficient Mismatch Repair and Microsatellite Instability Testing and Their Association with Clinicopathological Features in Colorectal Cancer. SHILAP Revista de lepidopterología. 2 indexed citations

11.

Liu, Kang, Peng Li, Yuanming Shen, et al.. (2020). Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8–MCM9 complex and compromises DNA mismatch repair in cancer cells. Cell Death and Disease. 11(7). 519–519. 29 indexed citations

12.

Tu, Hua, He Huang, Yi Ouyang, et al.. (2020). Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study. International Journal of Gynecological Cancer. 31(1). 129–133. 6 indexed citations

13.

Xie, Xuejun, et al.. (2020). Intraperitoneal chemotherapy as first-line treatment of newly diagnosed advanced epithelial ovarian cancer: Two centers' data in China. Gynecologic Oncology. 159. 348–348.

14.

Zhang, Xu, Yan Feng, Xinyu Wang, et al.. (2018). The inhibition of UBC13 expression and blockage of the DNMT1-CHFR-Aurora A pathway contribute to paclitaxel resistance in ovarian cancer. Cell Death and Disease. 9(2). 93–93. 26 indexed citations

15.

Shen, Yuanming, et al.. (2017). Clinical Predictors of Recurrence and Prognostic Value of Lymph Node Involvement in the Serous Borderline Ovarian Tumor. International Journal of Gynecological Cancer. 28(2). 279–284. 22 indexed citations

16.

Köster, Frank, Jin Li, Yuanming Shen, et al.. (2017). Effects of an Antagonistic Analog of Growth Hormone-Releasing Hormone on Endometriosis in a Mouse Model and In Vitro. Reproductive Sciences. 24(11). 1503–1511. 10 indexed citations

17.

Li, Yang, Fenfen Wang, Ying Li, et al.. (2014). MicroRNA Detection in Cervical Exfoliated Cells as a Triage for Human Papillomavirus–Positive Women. JNCI Journal of the National Cancer Institute. 106(9). 61 indexed citations

18.

Shen, Yuanming, F Ye, F Wang, et al.. (2013). miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer. British Journal of Cancer. 109(1). 92–99. 68 indexed citations

19.

Wang, Fenfen, Li Yang, Jiansong Zhou, et al.. (2011). miR-375 Is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion via Targeting Transcription Factor SP1. American Journal Of Pathology. 179(5). 2580–2588. 177 indexed citations

20.

Li, Yang, Fenfen Wang, Junfen Xu, et al.. (2011). Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV‐related target genes for miR‐29. The Journal of Pathology. 224(4). 484–495. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact